project id: TCGA-THCA; case submitter id: TCGA-EL-A3CR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.6; age at index: 78; days to birth: -28785; days to death: 233; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1924; year of death: 2002; age at diagnosis: 28785; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: Not Reported; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3278; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-EL-A3CR-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;